Invention Grant
- Patent Title: Dosing regimen for sedation with CNS 7056 (Remimazolam)
- Patent Title (中): 用中枢神经系统7056（雷莫唑仑）镇静剂量给药方案
-
Application No.: US13883935Application Date: 2011-11-07
-
Publication No.: US09561236B2Publication Date: 2017-02-07
- Inventor: Karin Wilhelm-Ogunbiyi , Keith Borkett , Gary Stuart Tilbrook , Hugh Wiltshire
- Applicant: Karin Wilhelm-Ogunbiyi , Keith Borkett , Gary Stuart Tilbrook , Hugh Wiltshire
- Applicant Address: GB Cambridge
- Assignee: PAION UK LTD.
- Current Assignee: PAION UK LTD.
- Current Assignee Address: GB Cambridge
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Cynthia L. Kanik
- Priority: EP10014366 20101108; EP10014784 20101119; EP10014819 20101122; EP10014972 20101125
- International Application: PCT/EP2011/005581 WO 20111107
- International Announcement: WO2012/062439 WO 20120518
- Main IPC: A61K31/5517
- IPC: A61K31/5517 ; A61K31/4468 ; A61K45/06
Abstract:
The invention relates to a dosing regimen for sedation with the fast-acting benzodiazepine CNS 7056 in combination with an opioid, in particular fentanyl, whereas CNS 7056 is given in a dose of 2 to 20 mg, preferably between 4 and 9 mg and most preferably between 5 and 8 mg.
Public/Granted literature
- US20140080815A1 DOSING REGIMEN FOR SEDATION WITH CNS 7056 (REMIMAZOLAM) Public/Granted day:2014-03-20
Information query
IPC分类:
